Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06602804 · ClinicalTrials.gov registry record · NA
Trima Non-DEHP Leukoreduced Red Blood Cell In Vivo Recovery Study
A NA study of Device Validation of In-vivo Performance, sponsored by Terumo BCT.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
- 2
- Study locations
NCT06602804 is a NA study of Device Validation of In-vivo Performance that has completed, run by Terumo BCT. The registered enrollment target is 37 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT06602804, a NA study of Device Validation of In-vivo Performance, has completed, sponsored by Terumo BCT.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is an in vivo 24-hour in-vivo recovery study of leukoreduced red blood cells (RBCs) collected on the Trima Accel System using Non-DEHP disposable sets and stored for 42 days.
Conditions Studied
Interventions
- DEVICE Trima Accel Auto RBC Collection
Study Locations (2)
Ohio
- Hoxworth Blood Center, University of Cincinnati College of Medicine - Cincinnati
Virginia
- American Red Cross, Norfolk Clinical Research Lab - Norfolk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2024-08-26 |
| Est. Completion | 2025-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06602804
The ClinicalTrials.gov registry entry for NCT06602804 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Terumo BCT, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Device Validation of In-vivo Performance appearing as the primary indexed condition, and to 1 intervention - of which Trima Accel Auto RBC Collection is the first listed.
NCT06602804 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Ohio, Virginia.
Frequently Asked Questions
What is clinical trial NCT06602804 about?
NCT06602804 is a clinical study titled "Trima Non-DEHP Leukoreduced Red Blood Cell In Vivo Recovery Study". This is an in vivo 24-hour in-vivo recovery study of leukoreduced red blood cells (RBCs) collected on the Trima Accel System using Non-DEHP disposable sets and stored for 42 days.
What is the current status of trial NCT06602804?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2024-08-26. Estimated completion is 2025-01-31.
What conditions does trial NCT06602804 study?
This clinical trial studies the following conditions: Device Validation of In-vivo Performance.
What interventions are being tested in trial NCT06602804?
The interventions under investigation include: Trima Accel Auto RBC Collection (DEVICE).
Who is sponsoring clinical trial NCT06602804?
This trial is sponsored by Terumo BCT, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06602804 being conducted?
This trial has 2 study locations across Ohio, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.